Company Filing History:
Years Active: 1998
Title: Roy Tyson Bass: Innovator in Somatostatin Antagonism
Introduction
Roy Tyson Bass is a notable inventor based in Somerset, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of somatostatin antagonists. His work has implications for enhancing growth and metabolic functions in mammals.
Latest Patents
Roy Tyson Bass holds a patent for a "Pure somatostatin antagonist and methods of use thereof." This patent describes a method for decreasing the effect of somatostatin, a peptide that plays a crucial role in regulating various physiological processes. The patent also details a peptide of formula I, which acts as a pure somatostatin antagonist. Additionally, it outlines methods for increasing the release of growth hormone, insulin, and glucagon in mammals, as well as a method for enhancing growth in these organisms.
Career Highlights
Roy Tyson Bass is associated with the American Cyanamid Company, where he has applied his expertise in biochemistry to advance research and development. His innovative work has positioned him as a key figure in the field of peptide research.
Collaborations
Throughout his career, Roy has collaborated with notable colleagues, including Brian Lee Buckwalter and John Richard Hadcock. These collaborations have contributed to the advancement of research in somatostatin antagonism and its applications.
Conclusion
Roy Tyson Bass is a distinguished inventor whose work in somatostatin antagonism has the potential to impact various medical and biological fields. His contributions continue to pave the way for future innovations in peptide research.